Emergence and Importance High Throughput Screening Market


High Throughput Screening is a process for scientific experimentation used in drug discovery and relevant to the fields of biology, materials science, and chemistry. The high throughput process development market is segmented into

  • Product and Services (Software, Instruments, Services, Consumables),
  • Technology (Chromatography, Ultraviolet light, and Other Technologies),
  • End-Users (Biopharmaceuticals, Contract Research Organizations, and Other End-users),
  • Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America).

The report offers the value (in USD million) for the above segments.

High Throughput Screening is the type of process that reduces development time and increases the amount of data accessible for the quality by design (QbD) approaches. The chromatography segment accounts for the largest share of the ion exchange. Owing to the advantages offered by chromatography over other technological segments such as high selectivity, and high flow rate, extensive removal of impurities such as host cells protein, DNA, and cell culture ultimately drives the market growth.

HTS development during COVID-19 Period

The COVID-19 pandemic bought an unexpected halt to the world. The health crisis that the world witnessed has had an unprecedented impact on various industries, specifically the healthcare and biotechnology industries. Strict regulations and restrictions imposed by the government led to slowing down the work in industries. Just within a few weeks into the pandemic, scientists discovered a list of molecules to overcome this crisis. According to the Human Vaccines and Therapeutics, in 2021, more than 70 vaccines were developed to combat COVID-19, 20 of which are in phase-3 trials. The high throughput process development has increased testing of new drug molecules, speeding up the drug discovery projects and thus has had a positive impact on this market.

The high throughput process development market is powered by an increase in investment in R&D, technological development, and the biopharmaceutical industry. In a 2020 article titled “A Single-use Strategy to Enable Manufacturing of Affordable Biologics” in the Computational and Biotechnology Journal states that the developing infrastructure and technology is the reason for the expansion of the high throughput process development market.

In biomanufacturing, the high throughput process development tools, and technology are used for simpler and faster development of the downstream chromatography process. High throughput tools help create chromatography conditions and media developments which can save time for process developers. Also due to the rising demand for manufacturing monoclonal antibodies, high throughput process development market has shown a tremendous increase.

Owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period. The main limitation of this market is a high investment cost in many R&D techniques and infrastructure, which may slow down its market growth. 

North America reported the highest high throughput screening market

Increased investment by the key market leaders and a demand for tools to produce biological material has boosted the growth in the United States . Hence, the growth of the studied market is anticipated in the North America Region.

Competitive Landscape

The high throughput screening market is consolidated in nature due to fewer companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies which hold the market shares. These companies include GE Healthcare, Merck KgAa, Danaher Corporation, Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., Sartorius AG, Agilent Technologies, Luminex Applikon, Tecan Trading AG, Eppendorf AG, and PerkinElmer Inc.

Recent Developments

In 2022, Scripps Research Institute has collaborated with scientists from University of North Carolina at Chapel Hill and Virginia Commonwealth University to map the key receptors in the human brain that moderates pleasure, pain, addiction, depression, psychosis, and related conditions using in vivo high throughput process development method.


Ritika Gupta

Ritika Gupta is an MPharm. graduate who is keen on spreading awareness about various unexplored medical fields through her writings.

Show More

Related Articles

Leave a Reply

Back to top button